The Economic Value of Medical Knowledge

Keywords

Foundation (evidence), Library science, Management, Value (mathematics), Political science

References

• R and D and productivity at the industry level: is there still a relationship. [Monograph]Zvi Griliches, Frank R. Lichtenberg — 1982
• Technology, Health Costs, and the NIHDavid Cutler — 1995
• The Value of Saving a Life: Evidence from the Labor MarketRichard H. Thaler, Sherwin Rosen — 1976
• Micro data and general equilibrium modelsMartin Browning, Lars Peter Hansen, James J. Heckman — 1999
• Intertemporal Substitution in ConsumptionRobert E. Hall — 1988
• Efficient Labor Contracts with Employment RiskRobert Topel, Finis Welch — 1986
• The Endogenous Determination of Time PreferenceGary S. Becker, Casey B. Mulligan — 1997
• Stochastic Consumption, Risk Aversion, and the Temporal Behavior of Asset ReturnsLars Peter Hansen, Kenneth J. Singleton — 1983
• Consumption, Income, and Interest Rates: Reinterpreting the Time Series EvidenceJohn Y. Campbell, N. Gregory Mankiw — 1989
• Measuring the Health of the U.S. PopulationDavid Cutler, Elizabeth A. Richardson, Theodore E. Keeler — 1997
• Preference Parameters and Behavioral Heterogeneity: An Experimental Approach in the Health and Retirement StudyRobert Barsky, F. Thomas Juster, Miles Kimball — 1997
• The value of risks to life and healthCharles Fried Viscusi — 1993
• Preference Parameters and Behavioral Heterogeneity: An Experimental Approach in the Health and Retirement SurveyRobert Barsky, Miles Kimball, F. Thomas Juster — 1995
• The Allocation of Publicly-Funded Biomedical ResearchFrank R. Lichtenberg — 1998
• The value of risks to life and healthW. Kip Viscusi — 1993

Cited by

• The Return to Biomedical Research: Treatment and Behavioral EffectsDavid Cutler, Srikanth Kadiyala, Robert Topel — 2003
• Evaluating Mergers in the Presence of Dynamic Competition Using Impacts on RivalsDarren Filson, Saman Olfati, Fatos Radoniqi — 2015
• An Empirical Study on the Relationship Between China's Human Development and Economic Growth (1978-2003)Pengfei Li, Jianghuai Zheng, Wei Zhang — 2006
• Is Medical Research Cost Effective?: Response to Murphy and TopelMark Siegler, Alix Weisfeld, David Cronin — 2003
• The impacts of the rise of Paragraph IV challenges on startup alliance formation and firm value in the pharmaceutical industry.Darren Filson, Ahmed Oweis — 2010
• COST-EFFECTIVENESS ANALYSIS IN THE REAL WORLD: THE CASE OF STATINSDavid P. Paul, Ambrose A. Bitziadis — 2002
• Black-White Differences in the Economic Value of Improving HealthKevin Murphy, Robert Topel — 2005
• How Does the Impact of an HIV/AIDS Information Campaign Vary with Educational Attainment? Evidence from Rural UgandaDamien de Walque — 2004
• The role of public health improvements in health advances: The twentieth-century United StatesDavid Cutler, Grant Miller — 2005
• Pharmaceutical high profits: the value of R&D, or oligopolistic rents?Janet Spitz, Mark Wickham — 2012
• Valuing statistical lives from observations of speed limits and driving behaviorJon Strand — 2009
• Sustainable Health Systems to Support InnovationPeter Sheehan, Bruce Rasmussen, Kim Sweeny — 2006
• Sanitary infrastructures and the decline of mortality in Germany, 1877–1913†Daniel Gallardo Albarrán — 2020
• Medical Progress and Health Care Financing : Research in Academic Medical Centers Following the 1997 Medicare CutsPierre Azoulay, Abigail Tay — 2003
• Is Medical Research Cost EffectiveM. Siegler, Alix Weisfeld, D. Cronin — 2003
• The Impacts of Price Controls on the Performance of the Pharmaceutical IndustryDarren Filson — 2007
• How Does the Impact of an HIV / AIDS Information Campaign Vary with Educational Attainment ?D. D. Walque, J. Nakiyingi, J. Pickering — 2004

Related papers

No related papers recorded.